Ordering Code | 4687 |
---|---|
Test Name | Herpes Simplex Type 1 & 2 Ab, IgG |
Alias | HSV-1 & HSV-2 IgG Antibodies IgG antibodies to Herpes Simplex Virus Type 1 & Type 2 HSV 1,2 Glycoprotein G, Specific IgG Antibodies |
Preferred Specimen | Serum |
Preferred Container | SST (Gold) |
Other Specimen/Container | Plasma in EDTA, K2 (Lavender), Plasma in Lithium Heparin (Green), Serum in Plain (Red) |
Optimum Volume | 0.5 mL |
Handling Instructions | Keep specimen &/or aliquot samples capped. |
Transport Requirements | Oahu: Refrigerated Airline: Refrigerated |
Specimen Stability | Ambient: 8 Hours Refrigerated: 7 Days Frozen: 1 Month |
Rejection Criteria | Hemolyzed, Insufficient quantity, Specimen older than stability limits, Wrong specimen type, No sample ID |
Avail. Stat | NO |
Analytic Time | Up to 4 Days |
Methodology | Multiplex Flow Immunoassay |
Reference range(s)
The reference ranges listed below are valid on this date of November 21, 2024.
Component | Age | Male Norm | Male Critical Low | Male Critical High | Female Norm | Female Critical High | Female Critical Low | Units | Add'l info |
---|---|---|---|---|---|---|---|---|---|
Herpes Simplex Type 1 Ab, IgG | ALL | AI | Antibody... Note1 | ||||||
Herpes Simplex Type 2 Ab, IgG | ALL | AI | Antibody... Note2 |
Note1:
Antibody
Index (AI) Result Interpretation
---------- -------- ---------------
< 0.9 Negative No HSV-1 IgG antibodies
detected. Patient is
presumed not to have had
previous HSV-1 infection.
0.9 - 1.0 Equivocal Equivocal results: Obtain
an additional sample for
re-testing.
>= 1.1 Positive IgG Antibody to HSV-1
detected.
____________________________________________________________________
See report..
Note2:
Antibody
Index (AI) Result Interpretation
---------- -------- --------------
< 0.9 Negative No HSV-2 IgG antibodies
detected. Patient is
presumed not to have had
previous HSV-2 infection.
0.9 - 1.0 Equivocal Equivocal results: Obtain
an additional sample for
re-testing.
>= 1.1 Positive IgG Antibody to HSV-2
detected.
____________________________________________________________________
See report..